These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3547726)

  • 21. Chemoradiotherapy laryngeal preservation for advanced hypopharyngeal cancer.
    Tai SK; Yang MH; Wang LW; Tsai TL; Chu PY; Wang YF; Huang JL; Chang SY
    Jpn J Clin Oncol; 2008 Aug; 38(8):521-7. PubMed ID: 18697758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Targeting of antitumor drugs with monoclonal antibodies].
    Monneret C; Florent JC
    Bull Cancer; 2000 Nov; 87(11):829-38. PubMed ID: 11125291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic results after irradiation of advanced hypopharyngeal cancer].
    Müller RP; Schertel L; Pötter R
    Sonderb Strahlenther Onkol; 1987; 81():44-7. PubMed ID: 3824131
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of chemotherapy for advanced oro and hypopharyngeal cancer.
    Kohno N
    Auris Nasus Larynx; 2004 Jun; 31(2):113-8. PubMed ID: 15121218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The syndrome of inappropriate antidiuretic hormone secretion associated with chemotherapy for hypopharyngeal cancer.
    Kusuki M; Iguchi H; Nakamura A; Nishiura H; Kanazawa A; Yamane H
    Acta Otolaryngol Suppl; 2004 Oct; (554):74-7. PubMed ID: 15513517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
    Ozer E; Grecula JC; Agrawal A; Rhoades CA; Schuller DE
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):385-9. PubMed ID: 16618907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [III. Non-Surgical Treatment Strategy for Locally Advanced Laryngeal and Hypopharyngeal Cancer].
    Kiyota N
    Gan To Kagaku Ryoho; 2017 Jul; 44(7):575-578. PubMed ID: 28790260
    [No Abstract]   [Full Text] [Related]  

  • 29. BR96-doxorubicin: been there, done that!
    Tolcher AW
    J Clin Oncol; 2000 Dec; 18(23):4000. PubMed ID: 11099337
    [No Abstract]   [Full Text] [Related]  

  • 30. [Surgery of the lymph drainage passages in oro- and hypopharyngeal cancer].
    Herberhold C
    Sonderb Strahlenther Onkol; 1987; 81():60-2. PubMed ID: 3824134
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemangiopericytoma of the head and neck.
    Gupta OP; Jain RK; Gupta S
    Ear Nose Throat J; 1985 Mar; 64(3):145-9. PubMed ID: 3979332
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combination treatment of hypopharyngeal cancer using endoscopic laser surgery and radiation follow-up].
    Steiner W; Herbst M
    Sonderb Strahlenther Onkol; 1987; 81():108-13. PubMed ID: 3824122
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
    Beckmann GK; Hoppe F; Pfreundner L; Flentje MP
    Head Neck; 2005 Jan; 27(1):36-43. PubMed ID: 15459918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
    Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
    Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypopharyngeal carcinoma: analysis of oncological and functional results after surgery].
    Lippi L; Polli G; Ciabatti PG
    Acta Otorhinolaryngol Ital; 1985; 5(1):19-28. PubMed ID: 4036586
    [No Abstract]   [Full Text] [Related]  

  • 36. [Application of chimeric Fab fragments of monoclonal antibody A7 for targeting chemotherapy against pancreatic cancer].
    Otsuji E; Yamaguchi T; Matsumura H; Nishida T; Yamamoto K; Tsuruta H; Okamoto K; Yata Y; Kitamura K; Takahashi T
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2285-7. PubMed ID: 9422075
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
    Urba SG; Moon J; Giri PG; Adelstein DJ; Hanna E; Yoo GH; Leblanc M; Ensley JF; Schuller DE
    J Clin Oncol; 2005 Jan; 23(1):88-95. PubMed ID: 15625363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality therapy for laryngeal and hypopharyngeal cancer.
    Sannazzari GL; Gabriele P; Redda MG; Verna R
    Rays; 1997; 22(3):360-71. PubMed ID: 9446940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects.
    Strome SE; Sausville EA; Mann D
    Oncologist; 2007 Sep; 12(9):1084-95. PubMed ID: 17914078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.